Advertisement
Advertisement
CAPR
Capricor Therapeutics Inc
4.09
USDSponsored
-0.09
-2.15%
Aug 07, 15:59 UTC -4
Closed
After-Market
4.14
+0.05
+1.22%
CAPR Earnings Reports
Positive Surprise Ratio
CAPR beat 22 of 39 last estimates.
56%
Next Report
In 3 Days
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.60
Implied change from Q1 26 (Revenue/ EPS)
--
/+1.69%
Implied change from Q2 25 (Revenue/ EPS)
--
/+7.14%
Capricor Therapeutics Inc earnings per share and revenue
On May 12, 2026, CAPR reported earnings of -0.59 USD per share (EPS) for Q1 26, missing the estimate of -0.54 USD, resulting in a -8.84% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.78% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of -0.60 USD, with revenue projected to reach -- USD, implying an increase of 1.69% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
FAQ
What were Capricor Therapeutics Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Capricor Therapeutics Inc reported EPS of -$0.59, missing estimates by -8.84%, and revenue of $0.00, 0% as expectations.
How did the market react to Capricor Therapeutics Inc's Q1 2026 earnings?
The stock price moved down -3.78%, changed from $31.52 before the earnings release to $30.33 the day after.
When is Capricor Therapeutics Inc expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Capricor Therapeutics Inc's next earnings report?
Based on 10
analysts, Capricor Therapeutics Inc is expected to report EPS of -$0.60 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement